SCHEMBL8287440

SCHEMBL8287440

O=C(O)/C=C/c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.36
AURKA O14965 1/20 0.36
GSK3A P49840 1/20 0.36
RHOA P61586 2/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ACHE P22303 1/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND2 P30279 1/20 0.34
CCND3 P30281 1/20 0.34
EGFR P00533 2/20 0.34
BTK Q06187 1/20 0.34
PDE11A Q9HCR9 1/20 0.33
PLA2G4A P47712 1/20 0.32
FLT3 P36888 1/20 0.32
BLK P51451 1/20 0.32
CSNK2A1 P68400 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285273 0.90 KDM4E (0.36) GSK3BGSK3ASMN1; SMN2CDK4CCND1
SCHEMBL8287196 0.85 GSK3B (0.37) GSK3BSMN1; SMN2CDK4CCND1CCND2
SCHEMBL8287205 0.82 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287593 0.81 GSK3B (0.37) GSK3BGSK3ARAB9ANPC1SMN1; SMN2
SCHEMBL8286162 0.80 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287945 0.80 S1PR1 (0.39) GSK3BAURKAGSK3ARHOACDK4
SCHEMBL8362929 0.79 PIK3CA (0.44) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286468 0.79 GSK3B (0.38) GSK3BGSK3ARAB9ANPC1SMN1; SMN2
SCHEMBL8285211 0.79 RAB9A (0.42) GSK3BAURKAGSK3ARHOARAB9A
SCHEMBL5872050 0.78 GAA (0.44) GSK3BSMN1; SMN2CDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed